NEW YORK, Feb 21 – Zygogen of Atlanta, Ga. will provide Curis with its proprietary transgenic zebrafish technology for use in drug discovery, Zygogen said Wednesday.

Zebrafish are similar to knockout mice in that they can serve as model organisms for finding genome-based drug targets, but they offer the advantage of being faster to breed and less expensive.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.